-
Posted by
Two Blokes Jul 25 -
Filed in
Stock
-
2 views
The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson , issued a correction for certain lots of a part related to its surgical stapler and classified the action as "most serious".
